2-[2-[4-(1,1,3,3-四甲基丁基)苯氧基]乙氧基]-乙醇 | 2315-61-9

• 物质功能分类: 分析化学 - 标准品 - 有机污染物标样
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-[2-[4-(1,1,3,3-四甲基丁基)苯氧基]乙氧基]-乙醇
• 中文别名: 2-{2-[4-(1,1,3,3-四甲基丁基)苯氧基]乙氧基}乙醇
• 英文名称: 2-{2-[4-(1,1,3,3-tetramethyl-butyl)-phenoxy]-ethoxy}-ethanol
• 英文别名: 4-tert-octylphenol diethoxylate；triton-X-100；2-{2-[4-(1,1,3,3-Tetramethylbutyl)phenoxy]ethoxy}ethanol；2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethanol
• CAS: 2315-61-9
• 化学式: C₁₈H₃₀O₃
• 分子量: 294.434
• InChiKey: LBCZOTMMGHGTPH-UHFFFAOYSA-N

物化性质

• 沸点：
  402.6±35.0 °C(Predicted)
• 密度：
  0.982±0.06 g/cm3(Predicted)
• 闪点：
  -17℃
• 溶解度：
  可溶于乙醇

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  21
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  38.7
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险品标志：
  F,Xi
• 安全说明：
  S16,S26,S61,S9
• 危险类别码：
  R11,R36,R52/53,R66,R67
• WGK Germany：
  1,2
• 海关编码：
  2909499000
• 储存条件：
  -20°C

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : 4-tert-Octylphenol diethoxylate solution
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 2315-61-9
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Flammable liquids (Category 2), H225
Eye irritation (Category 2), H319
Specific target organ toxicity - single exposure (Category 3), H336
Chronic aquatic toxicity (Category 3), H412
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
F Highly flammable R11
Xi Irritant R36
R66, R67
R52/53
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Danger
Hazard statement(s)
H225 Highly flammable liquid and vapour.
H319 Causes serious eye irritation.
H336 May cause drowsiness or dizziness.
H412 Harmful to aquatic life with long lasting effects.
Precautionary statement(s)
P210 Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
P273 Avoid release to the environment.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard information (EU)
EUH066 Repeated exposure may cause skin dryness or cracking.
According to European Directive 67/548/EEC as amended.
Hazard symbol(s) F Highly flammable
Xi Irritant
R-phrase(s)
R11 Highly flammable.
R36 Irritating to eyes.
R52/53 Harmful to aquatic organisms, may cause long-term adverse effects in
the aquatic environment.
R66 Repeated exposure may cause skin dryness or cracking.
R67 Vapours may cause drowsiness and dizziness.
S-phrase(s)
S16 Keep away from sources of ignition - No smoking.
S26 In case of contact with eyes, rinse immediately with plenty of water and
seek medical advice.
S61 Avoid release to the environment. Refer to special instructions/ Safety
data sheets.
Other hazards - none

---

SECTION 3: Composition/information on ingredients
Mixtures
Synonyms : 2-{2-[4-(1,1,3,3-Tetramethylbutyl)phenoxy]ethoxy}ethanol
Formula : C18H30O3 C18H30O3
Molecular Weight : 294,43 g/mol
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
Acetone
CAS-No. 67-64-1 Flam. Liq. 2; Eye Irrit. 2; STOT <= 100 %
EC-No. 200-662-2 SE 3; H225, H319, H336,
Index-No. 606-001-00-8 EUH066
4-tert-Octylphenol diethoxylate Included in the Candidate List of Substances of Very High Concern
(SVHC) according to Regulation (EC) No. 1907/2006 (REACH)
CAS-No. 2315-61-9 Skin Irrit. 2; Eye Irrit. 2; STOT 0,025 - 0,25 %
SE 3; Aquatic Acute 1; Aquatic
Chronic 1; H315, H319, H335,
H410
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
Acetone
CAS-No. 67-64-1 F, Xi, R11 - R36 - R66 - R67 <= 100 %
EC-No. 200-662-2
Index-No. 606-001-00-8
4-tert-Octylphenol diethoxylate Included in the Candidate List of Substances of Very High Concern
(SVHC) according to Regulation (EC) No. 1907/2006 (REACH)
CAS-No. 2315-61-9 Xi, N, R36/37/38 - R50/53 0,025 - 0,25 %
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

---

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with
water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides
Carbon oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
Use water spray to cool unopened containers.

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid breathing vapours, mist or gas. Ensure adequate ventilation.
Remove all sources of ignition. Evacuate personnel to safe areas. Beware of vapours accumulating to
form explosive concentrations. Vapours can accumulate in low areas.
For personal protection see section 8.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the
environment must be avoided.
Methods and materials for containment and cleaning up
Contain spillage, and then collect with an electrically protected vacuum cleaner or by wet-brushing and
place in container for disposal according to local regulations (see section 13).
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.
Keep away from sources of ignition - No smoking.Take measures to prevent the build up of electrostatic
charge.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.
Recommended storage temperature: -20 °C
Specific end use(s)
A part from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under
appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
impervious clothing, Flame retardant antistatic protective clothing, The type of protective
equipment must be selected according to the concentration and amount of the dangerous
substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator
with multi-purpose combination (US) or type AXBEK (EN 14387) respirator cartridges as a backup
to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air
respirator. Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into
the environment must be avoided.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: liquid, clear
Colour: colourless
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing -94,0 °C
point
f) Initial boiling point and 56,0 °C
boiling range
g) Flash point -17,0 °C - closed cup
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower Upper explosion limit: 13 %(V)
flammability or Lower explosion limit: 2 %(V)
explosive limits
k) Vapour pressure 533,3 hPa at 39,5 °C
245,3 hPa at 20,0 °C
l) Vapour density no data available
m) Relative density 0,79 g/cm3
n) Water solubility soluble
o) Partition coefficient: n- log Pow: -0,24
octanol/water
p) Auto-ignition 465,0 °C
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
Heat, flames and sparks. Extremes of temperature and direct sunlight.
Incompatible materials
Bases, Oxidizing agents, Reducing agents, Acetone reacts violently with phosphorous oxychloride.
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
LD50 Oral - rat - 5.800 mg/kg
Remarks: Behavioral:Altered sleep time (including change in righting reflex). Behavioral:Tremor.
LC50 Inhalation - rat - 8 h - 50.100 mg/m3
Inhalation: no data available
LD50 Dermal - guinea pig - 7.426 mg/kg
Skin corrosion/irritation
Skin - rabbit
Result: Mild skin irritation - 24 h
Serious eye damage/eye irritation
Eyes - rabbit
Result: Eye irritation - 24 h
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
This product is or contains a component that is not classifiable as to its carcinogenicity based on its IARC,
ACGIH, NTP, or EPA classification.
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
May cause drowsiness or dizziness.
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Kidney - Irregularities - Based on Human Evidence

---

SECTION 12: Ecological information
Toxicity
no data available
Toxicity to daphnia and EC50 - Daphnia magna (Water flea) - 13.500,00 mg/l - 48 h
other aquatic
invertebrates
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
Harmful to aquatic life with long lasting effects.
no data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Burn in a chemical incinerator equipped with an afterburner and scrubber but exert extra care in igniting
as this material is highly flammable. Offer surplus and non-recyclable solutions to a licensed disposal
company.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: 1090 IMDG: 1090 IATA: 1090
UN proper shipping name
ADR/RID: ACETONE, SOLUTION
IMDG: ACETONE, SOLUTION
IATA: Acetone, SOLUTION
Transport hazard class(es)
ADR/RID: 3 IMDG: 3 IATA: 3
Packaging group
ADR/RID: II IMDG: II IATA: II
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

---

SECTION 15 - REGULATORY INFORMATION
N/A

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-[2-[4-(1,1,3,3-四甲基丁基)苯氧基]乙氧基]-乙醇 在 lithium aluminium tetrahydride 、 sodium hydride 作用下， 以 四氢呋喃 为溶剂， 生成 2-[2-[2-(2-辛基苯氧基)乙氧基]乙氧基]乙醇
  参考文献：
  名称：

  Isolation of Bacterial Strains that Produce the Endocrine Disruptor, Octylphenol Diethoxylates, in Paddy Fields

  摘要：

  从日本西部的36个不同水稻田收集了表层土壤样本。每个土壤样本都跟含有0.2% OPPEO的基础盐培养基一起孵育。十二个样本表现出OPPEO降解活性，分别从中分离出十二种OPPEO降解细菌。所分离的细菌在含有0.2% OPPEO作为唯一碳源的培养基上生长，在好氧条件下积累了OP2EO和OP3EO。在本实验中，通常与OP2EO一起在地表水中被识别的OP1EO和辛基酚并未被观察到。通过BIOLOG和16S rDNA RFLP分析，所分离的细菌为革兰氏阴性，初步鉴定为假单胞菌（Pseudomonas putida，10个分离株）和伯克霍尔德菌（Burkholderia cepacia，一个分离株）。

  DOI：

  10.1271/bbb.66.1792
• 作为产物：
  描述：

  辛基酚聚醚-3 在 lithium aluminium tetrahydride 、 sodium hydride 作用下， 以 四氢呋喃 为溶剂， 反应 4.0h， 生成 2-[2-[4-(1,1,3,3-四甲基丁基)苯氧基]乙氧基]-乙醇
  参考文献：
  名称：

  Isolation of Bacterial Strains that Produce the Endocrine Disruptor, Octylphenol Diethoxylates, in Paddy Fields

  摘要：

  从日本西部的36个不同水稻田收集了表层土壤样本。每个土壤样本都跟含有0.2% OPPEO的基础盐培养基一起孵育。十二个样本表现出OPPEO降解活性，分别从中分离出十二种OPPEO降解细菌。所分离的细菌在含有0.2% OPPEO作为唯一碳源的培养基上生长，在好氧条件下积累了OP2EO和OP3EO。在本实验中，通常与OP2EO一起在地表水中被识别的OP1EO和辛基酚并未被观察到。通过BIOLOG和16S rDNA RFLP分析，所分离的细菌为革兰氏阴性，初步鉴定为假单胞菌（Pseudomonas putida，10个分离株）和伯克霍尔德菌（Burkholderia cepacia，一个分离株）。

  DOI：

  10.1271/bbb.66.1792
• 作为试剂：
  描述：

  二氧化碳 、 、 D-2-脱氧葡萄糖 在 二甲基亚砜 、 乙醇 、 乙酸乙酯 、 4-羟乙基哌嗪乙磺酸 、 磷酸肌酸 、 2-[2-[4-(1,1,3,3-四甲基丁基)苯氧基]乙氧基]-乙醇 作用下， 以 4-羟乙基哌嗪乙磺酸 为溶剂， 反应 34.17h， 生成 葡萄糖
  参考文献：
  名称：

  Remedy

  摘要：

  本发明涉及一种治疗伴随胰岛素或胰岛素反应异常的疾病的治疗剂和预防剂，一种类似胰岛素的作用剂，一种用于治疗预防伴随胰岛素或胰岛素反应异常的疾病的食品、饮料和饲料，一种促进葡萄糖进入细胞的剂和一种诱导分化成脂肪细胞的剂，其特征在于每种剂都包含至少一种从以下植物中选择的加工产品作为有效成分：(a) 属于锦葵科的植物，(b) 属于姜科的植物，(c) 属于菊科的植物，(d) 属于百合科的植物，以及(e) 属于蓼科的植物。

  公开号：

  US20060216362A1

文献信息

• 1,1-DI[(ALKYLPHENOXY)ETHOXY]CYCLOHEXANES
  申请人：Bonham James A.

  公开号：US20130197274A1

  公开（公告）日：2013-08-01

  Disclosed is a ketal having the formula: wherein R′ and R″ independently are an alkyl group having from 8 to about 20 carbon atoms; m and n independently are an integer of from 1 to about 200; and r and s independently are an integer of from 1 to 3; and the method for preparing the ketal by transketalization using 1,1-dimethoxycyclohexane or 1,1-diethoxycyclohexane with an (alkoxyphenoxy)ethanol type of surfactant. The ketal is at least partially soluble in water.

  揭示了具有以下化学式的酮醇：其中R′和R″分别为具有8至约20个碳原子的烷基基团；m和n分别为1至约200的整数；r和s分别为1至3的整数；以及通过使用1,1-二甲氧基环己烷或1,1-二乙氧基环己烷与(烷氧基苯氧基)乙醇型表面活性剂进行转酮缩合制备酮醇的方法。该酮醇至少部分可溶于水。
• Treatment of inflammation with 2,4,6-trihydroxy-alpha-para-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives
  申请人：PARKER HUGHES INSTITUTE

  公开号：US20020010217A1

  公开（公告）日：2002-01-24

  2,4,6-trihydroxy-&agr;-p-methoxyphenylacetophenone (also identified herein as “D-58”), or its pharmaceutically acceptable derivatives such as salt and ester forms, is administered for inhibiting inflammatory reactions. The treatment can be remedial or prophylactic. Examples of the conditions that can be treated include acute inflammatory reactions and allergic inflammatory reactions, and specific examples include allergy, asthma, arthritis, psoriasis, skin sunburn, inflammatory pelvic disease, inflammatory bowel disease, urethritis, uvitis, senusitis, pneumonitis, encephalitis, meningitis, myocarditis, nephritis, osteomyelitis, myositis, hepatitis, gastritis, enteritis, dermatitis, gingivitis, appendicitis, pancreatitis, cholocystitis and cholangitis. The 2,4,6-trihydroxy-&agr;-p-methoxyphenylacetophenone can be administered by various routes as needed.

  2,4,6-三羟基-&agr;-p-甲氧基苯乙酮（在此处也称为“D-58”），或其药学上可接受的衍生物，如盐和酯形式，可用于抑制炎症反应。治疗可以是治疗性或预防性的。可以治疗的病症包括急性炎症反应和过敏性炎症反应，具体的例子包括过敏、哮喘、关节炎、牛皮癣、皮肤晒伤、盆腔炎症、炎症性肠病、尿道炎、葡萄膜炎、鼻窦炎、肺炎、脑炎、脑膜炎、心肌炎、肾炎、骨髓炎、肌炎、肝炎、胃炎、肠炎、皮炎、牙龈炎、阑尾炎、胰腺炎、胆囊炎和胆管炎。2,4,6-三羟基-&agr;-p-甲氧基苯乙酮可以根据需要通过各种途径给予。
• Process for the preparation of iodophor compounds and methods for
  申请人：The Purdue Frederick Company

  公开号：US04113857A1

  公开（公告）日：1978-09-12

  An improved process for preparing iodophor preparations which comprises adding an ion selected from the group consisting of iodate, bromate, chlorite, chromate, hypochlorite, permanganate and persulfate ions and hydrogen peroxide to the iodine carrier selected from the group consisting of povidone, cationic, anionic and nonionic detergent compounds and an iodide salt, to result in a substantially pure iodophor compound which is virtually free of autodegraded iodide ion contamination and unreacted elemental iodine, said iodophor compounds exhibiting an enhanced stability. The process is also applicable to eliminate the presence of elemental iodine contaminants, iodide contamination and loss of titratable iodine during the process preparing pharmaceutical dosage forms containing iodophor active ingredients to enhance the stability and potency of the respective product.

  一种改进的制备碘酚制剂的方法，包括向从碘酸盐、溴酸盐、次氯酸盐、铬酸盐、次氯酸盐、高锰酸盐和过硫酸盐离子组成的离子中选择的离子和过氧化氢添加碘载体，所述碘载体从聚维酮、阳离子、阴离子和非离子洗涤剂化合物和碘化物盐组成的组中选择，以得到一种基本上纯净的碘酚化合物，该化合物几乎没有自降解碘化物离子污染和未反应的元素碘，所述碘酚化合物具有增强的稳定性。该方法还适用于消除元素碘污染、碘化物污染和在制备含碘酚活性成分的制药剂量形式的过程中失去可滴定碘的存在，以增强各自产品的稳定性和效力。
• Treatment of inflammation with 2,4,6-trihydroxy-alpha-rho-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives
  申请人：Parker Hughes Institute

  公开号：US06248790B1

  公开（公告）日：2001-06-19

  2,4,6-trihydroxy-&agr;-p-methoxyphenylacetophenone (also identified herein as “D-58”), or its pharmaceutically acceptable derivatives such as salt and ester forms, is administered for inhibiting inflammatory reactions. The treatment can be remedial or prophylactic. Examples of the conditions that can be treated include acute inflammatory reactions and allergic inflammatory reactions, and specific examples include allergy, asthma, arthritis, psoriasis, skin sunburn, inflammatory pelvic disease, inflammatory bowel disease, urethritis, uvitis, senusitis, pneumonitis, encephalitis, meningitis, myocarditis, nephritis, osteomyelitis, myositis, hepatitis, gastritis, enteritis, dermatitis, gingivitis, appendicitis, pancreatitis, cholocystitis and cholangitis. The 2,4,6-trihydroxy-&agr;-p-methoxyphenylacetophenone can be administered by various routes as needed.

  2,4,6-三羟基-&agr;-对甲氧基苯乙酮（在此处也称为“D-58”），或其药学上可接受的衍生物，如盐和酯形式，可用于抑制炎症反应。治疗可以是治疗性的或预防性的。可以治疗的病症包括急性炎症反应和过敏性炎症反应，具体例子包括过敏、哮喘、关节炎、牛皮癣、皮肤晒伤、炎性盆腔疾病、炎性肠病、尿道炎、葡萄膜炎、鼻窦炎、肺炎、脑炎、脑膜炎、心肌炎、肾炎、骨髓炎、肌炎、肝炎、胃炎、肠炎、皮炎、牙龈炎、阑尾炎、胰腺炎、胆囊炎和胆管炎。2,4,6-三羟基-&agr;-对甲氧基苯乙酮可以按需要通过各种途径给药。
• Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes
  申请人：McDaniel C. Steven

  公开号：US20100210745A1

  公开（公告）日：2010-08-19

  Disclosed herein are polymeric materials such as a coating, a plastic, a laminate, a composite, an elastomer, an adhesive, or a sealant; a surface treatment such as a textile finish or a wax; a filler for such a polymeric material or a surface treatment that includes an enzyme such as an esterase (e.g., a lipolytic enzyme, a sulfuric ester hydrolase, an organophosphorus compound degradation enzyme), an enzyme (e.g., a lysozyme, a lytic transglycosylase) that degrades a cell wall and/or a cell membrane component, a biocidal or biostatic peotide, and/or a peptidase. Also disclosed herein are methods of altering a material's property such as service life, flexability, or rigidity, by incorporation of an enzyme into a material capable of being chemically crosslinked by the activity of a lipolytic enzyme, a hydrolase, and/or a urease.

  本文公开了一些聚合材料，如涂层、塑料、层压板、复合材料、弹性体、粘合剂或密封剂；一种表面处理，如纺织品涂层或蜡；一种填料，用于这样的聚合材料或表面处理，其中包括一种酶，如酯酶（例如，脂肪水解酶，硫酸酯水解酶，有机磷化合物降解酶），降解细胞壁和/或细胞膜成分的酶（例如，溶菌酶，裂解转糖基酶），生物杀菌或生物静态肽，以及/或肽酶。本文还公开了通过将酶纳入可通过脂肪水解酶、水解酶和/或脲酶的活性交联材料中来改变材料性能，如使用寿命、柔韧性或刚度的方法。